VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value ($000): $921,764 (100.0% shares, 0.0% debt)

Holdings (28)

— INSTIL BIO INC 18.7%

Value ($000) $172,176 Shares 6,865,076 Est. Cost $25.08 Unrealized —

— CONSTELLATION PHARMACEUTICAL 10.2%

Value ($000) $93,955 Shares 4,016,873 Est. Cost $31.43 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 10.2%

Value ($000) $93,759 Shares 3,720,582 Est. Cost $11.50 Unrealized +70.1%

OLMA OLEMA PHARMACEUTICALS INC 5.5%

Value ($000) $50,971 Shares 1,536,193 Est. Cost $46.89 Unrealized -8.6%

ALT ALTIMMUNE INC 5.4%

Value ($000) $49,455 Shares 3,500,000 Est. Cost $5.49 Unrealized +194.3%

CGEM CULLINAN MANAGEMENT INC 5.3%

Value ($000) $49,010 Shares 1,176,145 Est. Cost $40.60 Unrealized 0.0%

— KINNATE BIOPHARMA INC 5.0%

Value ($000) $45,899 Shares 1,473,014 Est. Cost $39.78 Unrealized —

— TRILLIUM THERAPEUTICS INC 4.7%

Value ($000) $43,390 Shares 4,040,000 Est. Cost $4.63 Unrealized —

— MARINUS PHARMACEUTICALS INC 4.4%

Value ($000) $40,895 Shares 2,641,809 Est. Cost $12.27 Unrealized —

— VISTAGEN THERAPEUTICS INC 3.8%

Value ($000) $34,725 Shares 16,302,596 Est. Cost $2.02 Unrealized —

— ATHIRA PHARMA INC 3.4%

Value ($000) $31,126 Shares 1,691,623 Est. Cost $20.05 Unrealized —

RLMD RELMADA THERAPEUTICS INC 3.3%

Value ($000) $30,041 Shares 853,206 Est. Cost $39.16 Unrealized -10.7%

CLDX CELLDEX THERAPEUTICS INC 2.8%

Value ($000) $25,557 Shares 1,240,610 Est. Cost $15.71 Unrealized +46.2%

PHVS PHARVARIS BV 2.7%

Value ($000) $25,335 Shares 902,882 Est. Cost $31.46 Unrealized 0.0%

KROS KEROS THERAPEUTICS INC 2.5%

Value ($000) $22,915 Shares 372,306 Est. Cost $30.81 Unrealized +105.6%

— ESSA PHARMA INC 2.0%

Value ($000) $18,178 Shares 625,754 Est. Cost $29.05 Unrealized —

KURA KURA ONCOLOGY INC 1.8%

Value ($000) $16,255 Shares 575,000 Est. Cost $14.42 Unrealized +119.3%

SNDX SYNDAX PHARMACEUTICALS INC 1.4%

Value ($000) $13,232 Shares 591,782 Est. Cost $17.65 Unrealized +28.0%

— ADICET BIO INC 1.4%

Value ($000) $13,080 Shares 1,000,000 Est. Cost $13.08 Unrealized —

— APTOSE BIOSCIENCES INC 1.0%

Value ($000) $9,592 Shares 1,605,400 Est. Cost $5.97 Unrealized —

COGT COGENT BIOSCIENCES INC 1.0%

Value ($000) $9,560 Shares 1,088,817 Est. Cost $10.99 Unrealized -12.4%

— ALIGOS THERAPEUTICS INC 1.0%

Value ($000) $9,286 Shares 408,377 Est. Cost $27.65 Unrealized —

EYPT EYEPOINT PHARMACEUTICALS INC 0.8%

Value ($000) $7,112 Shares 700,000 Est. Cost $11.25 Unrealized 0.0%

— BCTG ACQUISITION CORP 0.6%

Value ($000) $5,560 Shares 500,000 Est. Cost $10.36 Unrealized —

— METACRINE INC 0.5%

Value ($000) $4,216 Shares 680,000 Est. Cost $10.21 Unrealized —

SPRY SILVERBACK THERAPEUTICS INC 0.4%

Value ($000) $3,709 Shares 85,000 Est. Cost $33.40 Unrealized +41.7%

TSHA TAYSHA GENE THERAPIES INC 0.3%

Value ($000) $2,449 Shares 120,649 Est. Cost $23.90 Unrealized +13.3%

VRDN VIRIDIAN THERAPEUTICS INC 0.0%

Value ($000) $326 Shares 19,495 Est. Cost $15.07 Unrealized +24.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	INSTIL BIO INC	6,865,076	$172,176	18.7%	$25.08	—	COM	45783C101
—	CONSTELLATION PHARMACEUTICAL	4,016,873	$93,955	10.2%	$31.43	—	COM	210373106
ACRS	ACLARIS THERAPEUTICS INC	3,720,582	$93,759	10.2%	$11.50	+70.1%	COM	00461U105
OLMA	OLEMA PHARMACEUTICALS INC	1,536,193	$50,971	5.5%	$46.89	-8.6%	COM	68062P106
ALT	ALTIMMUNE INC	3,500,000	$49,455	5.4%	$5.49	+194.3%	COM	02155H200
CGEM	CULLINAN MANAGEMENT INC	1,176,145	$49,010	5.3%	$40.60	0.0%	COM	230031106
—	KINNATE BIOPHARMA INC	1,473,014	$45,899	5.0%	$39.78	—	COM	49705R105
—	TRILLIUM THERAPEUTICS INC	4,040,000	$43,390	4.7%	$4.63	—	COM	89620X506
—	MARINUS PHARMACEUTICALS INC	2,641,809	$40,895	4.4%	$12.27	—	COM	56854Q200
—	VISTAGEN THERAPEUTICS INC	16,302,596	$34,725	3.8%	$2.02	—	COM	92840H202
—	ATHIRA PHARMA INC	1,691,623	$31,126	3.4%	$20.05	—	COM	04746L104
RLMD	RELMADA THERAPEUTICS INC	853,206	$30,041	3.3%	$39.16	-10.7%	COM	75955J402
CLDX	CELLDEX THERAPEUTICS INC	1,240,610	$25,557	2.8%	$15.71	+46.2%	COM	15117B202
PHVS	PHARVARIS BV	902,882	$25,335	2.7%	$31.46	0.0%	COM	N69605108
KROS	KEROS THERAPEUTICS INC	372,306	$22,915	2.5%	$30.81	+105.6%	COM	492327101
—	ESSA PHARMA INC	625,754	$18,178	2.0%	$29.05	—	COM	29668H708
KURA	KURA ONCOLOGY INC	575,000	$16,255	1.8%	$14.42	+119.3%	COM	50127T109
SNDX	SYNDAX PHARMACEUTICALS INC	591,782	$13,232	1.4%	$17.65	+28.0%	COM	87164F105
—	ADICET BIO INC	1,000,000	$13,080	1.4%	$13.08	—	COM	007002108
—	APTOSE BIOSCIENCES INC	1,605,400	$9,592	1.0%	$5.97	—	COM	03835T200
COGT	COGENT BIOSCIENCES INC	1,088,817	$9,560	1.0%	$10.99	-12.4%	COM	19240Q201
—	ALIGOS THERAPEUTICS INC	408,377	$9,286	1.0%	$27.65	—	COM	01626L105
EYPT	EYEPOINT PHARMACEUTICALS INC	700,000	$7,112	0.8%	$11.25	0.0%	COM	30233G209
—	BCTG ACQUISITION CORP	500,000	$5,560	0.6%	$10.36	—	COM	05492W103
—	METACRINE INC	680,000	$4,216	0.5%	$10.21	—	COM	59101E103
SPRY	SILVERBACK THERAPEUTICS INC	85,000	$3,709	0.4%	$33.40	+41.7%	COM	82835W108
TSHA	TAYSHA GENE THERAPIES INC	120,649	$2,449	0.3%	$23.90	+13.3%	COM	877619106
VRDN	VIRIDIAN THERAPEUTICS INC	19,495	$326	0.0%	$15.07	+24.2%	COM	92790C104